Development and selection of Valpha l4i NKT cells

Area of Science:

• Immunology
• Cell Biology
• Developmental Biology

Background:

• Invariant natural killer T (Valpha14i NKT) cells bridge innate and adaptive immunity, exhibiting characteristics of both NK cells and T cells.
• These cells utilize a semi-invariant T cell receptor (TCR) comprising a Valpha14-Jalpha18 chain, recognizing CD1d-presented glycolipids.

Purpose of the Study:

• To elucidate the unique developmental pathway of Valpha14i NKT cells.
• To identify key regulatory mechanisms governing Valpha14i NKT cell development.
• To explore the role of CD1d-mediated signaling in Valpha14i NKT cell lineage commitment.

Main Methods:

• Analysis of thymocyte development and Valpha14i NKT cell maturation.
• Investigation of TCR rearrangement and CD1d-glycolipid interactions.
• Assessment of signaling pathways including Fyn/SAP/SLAM, NFkappaB, T-bet, and IL-15.

Main Results:

• Valpha14i NKT cell development is initiated in CD4+CD8+ thymocytes through interaction with CD1d-expressing cells.
• Maturation involves upregulation of activation markers (e.g., CD44) and expression of NK-related molecules (e.g., NKI.1, Ly-49 receptors).
• Specific signaling pathways (Fyn/SAP/SLAM, NFkappaB, T-bet, IL-15) critically regulate Valpha14i NKT cell development.

Conclusions:

• The development of Valpha14i NKT cells is distinct from conventional T cells, requiring unique signaling cues.
• CD1d-restricted glycolipid recognition is essential for the positive selection and lineage commitment of Valpha14i NKT cells.
• The developmental paradigm of Valpha14i NKT cells may inform the study of other unconventional T cell subsets.